Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
D-dimer levels predict COVID-19 severity and mortality. Authors' reply.
Kałużna-Oleksy M, Gackowski A, Jankowska EA, Kukulski T, Lelonek M, Nessler J, Pawlak A, Rozentryt P, Rubiś P, Straburzyńska-Migaj E, Leszek P. Kałużna-Oleksy M, et al. Kardiol Pol. 2021 Feb 25;79(2):218-219. doi: 10.33963/KP.15831. Epub 2021 Feb 25. Kardiol Pol. 2021. PMID: 33635035 Free article. No abstract available.
Patients with heart failure and concomitant chronic obstructive pulmonary disease participating in the Heart Failure Pilot Survey (ESC-HF Pilot) - Polish population.
Straburzyńska-Migaj E, Kałużna-Oleksy M, Maggioni AP, Grajek S, Opolski G, Ponikowski P, Jankowska E, Balsam P, Poloński L, Drożdż J. Straburzyńska-Migaj E, et al. Arch Med Sci. 2015 Aug 12;11(4):743-50. doi: 10.5114/aoms.2014.47878. Epub 2015 Jan 14. Arch Med Sci. 2015. PMID: 26322085 Free PMC article.
An asymptomatic giant thoracoabdominal aortic aneurysm.
Kałużna-Oleksy M, Żabicki B, Straburzyńska-Migaj E, Grajek S. Kałużna-Oleksy M, et al. Kardiol Pol. 2015;73(11):1122. doi: 10.5603/KP.2015.0230. Kardiol Pol. 2015. PMID: 26726727 Free article. No abstract available.
Initial clinical experience with the first drug (sacubitril/valsartan) in a new class - angiotensin receptor neprilysin inhibitors in patients with heart failure with reduced left ventricular ejection fraction in Poland.
Kałużna-Oleksy M, Kolasa J, Migaj J, Pawlak A, Lelonek M, Nessler J, Straburzyńska-Migaj E. Kałużna-Oleksy M, et al. Kardiol Pol. 2018;76(2):381-387. doi: 10.5603/KP.a2017.0230. Epub 2017 Dec 1. Kardiol Pol. 2018. PMID: 29192956 Free article.
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world.
Kapelios CJ, Lainscak M, Savarese G, Laroche C, Seferovic P, Ruschitzka F, Coats A, Anker SD, Crespo-Leiro MG, Filippatos G, Piepoli MF, Rosano G, Zanolla L, Aguiar C, Murin J, Leszek P, McDonagh T, Maggioni AP, Lund LH; Heart Failure Long-Term Registry Investigators. Kapelios CJ, et al. Eur J Heart Fail. 2019 Nov;21(11):1383-1397. doi: 10.1002/ejhf.1532. Epub 2019 Jun 18. Eur J Heart Fail. 2019. PMID: 31132222 Free article.
79 results